Abstract:Abstract Background Age‐related neurodegeneration characteristic of late‐onset Alzheimer’s disease (LOAD) begins in middle age, well before symptoms. Therefore, translational models to identify modifiable risk factors in middle‐age are needed to understand the etiology and identify early therapeutic targets for intervention. Vervet monkeys ( Chlorocebus aethiops sabaeus ), like humans, have complex central nervous systems and naturally develop several risk factors for LOAD with age, including obesity, prediabetes, hypertension and decline in physical function. Furthermore, aged vervets also recapitulate many of the characteristics of early AD that are associated with reduced brain volumes, including human‐like Aβ accumulation in the brain, greater Aβ plaque burden, and reduced CSF Aβ. Thus, these NHPs are ideal models for studying healthy versus neuropathological aging. Method Using structural magnetic resonance imaging and cognitive assessments, we examined the relationships between age, working memory, and neuroanatomy by measuring the thicknesses and volumes of AD‐signature cortical regions of interest (“meta‐ROIs”) in 46 middle‐aged to elderly female vervets (8‐29 years of age). Result Using linear mixed effects models with age as a fixed effect and individual as a random effect, we found that cortical gray matter volume significantly decreased with increasing age (β=‐51.94, SE=14.37; t=‐3.61; p<0.001). The thickness of the AD‐signature meta‐ROIs was not affected by age (β<0.01, SE<0.01; t=‐0.19; p=0.85), however, the volumetric meta‐ROI tended to decline with age in older animals (β=‐6.95, SE= 4.20; t=‐1.65; p= 0.098). In the precuneus, a component region of the meta‐ROI that has been shown to be reduced in preclinical AD, volume decreased with increasing age (β=‐1.69, SE=0.72; t=‐2.36; p= 0.023). In addition to these age‐related effects, the volume of the AD‐signature meta‐ROI was positively correlated with performance on the delayed response test of working memory (R= 0.235; p=0.026). Conclusion Taken together, these findings demonstrate that cortical gray matter diminishes with age in vervet monkeys in regions relevant to AD risk, and is associated with cognitive impairment. This study provides important insights about the relationships between age, neuroanatomy, and memory in vervets, and lays the groundwork for future investigations to identify at‐risk phenotypes such that therapeutic interventions may be tested in this nonhuman primate model.

Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study

Cortical gray matter volume and working memory in a NHP model of AD‐like neuropathology

A nonhuman primate model with Alzheimer's disease-like pathology induced by hippocampal overexpression of human tau

Rhesus monkeys as a translational model for late‐onset Alzheimer's disease

Alzheimer disease-like neuropathologic changes in a geriatric baboon (Papio hamadryas)

Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease

Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathology

Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology

Naturally occurring histological findings and Alzheimer's-like pathology in the brain of aging African green monkeys (Chlorocebus sabaeus)

A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis

Modeling neurodegenerative diseases using non-human primates: advances and challenges

Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming

Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition

Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer’s disease in nonhuman primates

Early blood immune molecular alterations in cynomolgus monkeys with a PSEN1 mutation causing familial Alzheimer's disease

Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing

Human Alzheimer's Disease ATN/ABC Staging Applied to Aging Rhesus Macaque Brains: Association With Cognition and MRI‐Based Regional Gray Matter Volume

Lack of Human-Like Extracellular Sortilin Neuropathology in Transgenic Alzheimer’s Disease Model Mice and Macaques

Age-associated changes of cerebrospinal fluid amyloid-β and tau in cynomolgus monkeys

Alzheimer's Disease Neuropathological Change in Aged Non-Primate Mammals